INTERNATIONAL PATENT: AMGEN INC., IDEAYA BIOSCIENCES, INC. FILES APPLICATION FOR "CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS AND MAT2A INHIBITORS"

GENEVA, Dec. 10 -- AMGEN INC. (One Amgen Center DriveThousand Oaks, CA 91320-1799), IDEAYA BIOSCIENCES, INC. (5000 Shoreline CourtSuite 300South San Francisco, CA 94080) filed a patent application (PCT/US2025/031091) for "CANCER TREATMENTS USING MTA-COOPERATIVE PRMT5 INHIBITORS AND MAT2A INHIBITORS" on May 28, 2025. With publication no. WO/2025/250569, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BELMONTES, Brian (c/o Amgen Inc.One Amgen Center Drive, Mail Stop 28-5-AThousand Oaks, CA 91320-1799), HUGHES, Paul, E. (c/o...